Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.96 USD | +2.12% | -1.47% | -19.83% |
Apr. 09 | Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing | MT |
Apr. 05 | Sector Update: Health Care Stocks Rise Friday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.83% | 6.87B | |
-1.33% | 105B | |
+3.42% | 97.5B | |
+1.86% | 22.19B | |
-16.28% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.28% | 14.52B | |
+4.94% | 14.09B | |
+29.24% | 10.99B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Oppenheimer Adjusts Cytokinetics Price Target to $60 From $57, Maintains Outperform Rating